Rapid7 potential sale ‘remains highly uncertain,’ says Mizuho

Mizuho analyst Gregg Moskowitz says that given Rapid7’s recent execution issues, a significantly revamped go-to-market strategy that will likely require an ample amount of time, and a "depressed valuation," the firm can understand the company’s decision to explore a sale. However, the outcome "remains highly uncertain at this early stage," the analyst tells investors in a research note. As such, Mizuho keeps a Neutral rating on Rapid7 with a $40 price after Reuters reported the company is currently in the process of exploring a potential sale and has hired bankers to facilitate.